These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 18942391)

  • 1. [Pharmacoeconomic evaluation of nosocomial pneumonia treatment].
    Krysanova IS; Kulikov AIu
    Antibiot Khimioter; 2008; 53(1-2):33-8. PubMed ID: 18942391
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparative pharmacoeconomic evaluation of various approaches to antibacterial therapy of ventilator-associated pneumonia].
    Rudnov VA
    Antibiot Khimioter; 2001; 46(12):22-6. PubMed ID: 12108089
    [No Abstract]   [Full Text] [Related]  

  • 3. [Nosocomial infections].
    de Zeeuw J; Rapp B; Huntemann M; Baberg HT
    Med Klin (Munich); 2005 May; 100(5):284-5. PubMed ID: 15902383
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparative study of the cost-/effectiveness relationship of initial therapy with imipenem/cilastatin in nosocomial pneumonia. Group study].
    Rodloff AC; Laubenthal HJ; Bastian A; Bestehorn K; Büchele G; Gaus W
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1996 Apr; 31(3):172-80. PubMed ID: 8672620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The attributable cost and length of hospital stay because of nosocomial pneumonia in intensive care units in 3 hospitals in Argentina: a prospective, matched analysis.
    Rosenthal VD; Guzman S; Migone O; Safdar N
    Am J Infect Control; 2005 Apr; 33(3):157-61. PubMed ID: 15798670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacoeconomic estimation of cost of community acquired pneumonia therapy].
    Kulidzhanov AIu; Sirotko II; Koriakin PM; Korchazhkin VS
    Voen Med Zh; 2001 Jan; 322(1):50-2. PubMed ID: 11219929
    [No Abstract]   [Full Text] [Related]  

  • 7. [Diagnosis and treatment of nosocomial pneumonia: bronchial fibroscopy, protected brushing and/or bronchial lavage is not indispensable].
    Marquette CH
    Rev Pneumol Clin; 2001 Apr; 57(2):124-31. PubMed ID: 11353918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The clinical and pharmacoeconomic aspects of gemifloxacin(corrected) use in the patients with extra-hospital pneumonia in stationary conditions].
    Zaĭtsev AA; Sinopal'nikova AI
    Voen Med Zh; 2007 Jan; 328(1):44-51. PubMed ID: 17436714
    [No Abstract]   [Full Text] [Related]  

  • 9. Nosocomial pneumonia.
    LeBas SJ; Grier LR; Campbell GD
    Curr Opin Pulm Med; 1996 May; 2(3):206-12. PubMed ID: 9363141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The clinical and economic aspects of treating community-acquired pneumonias].
    Tiurin VP; Dmitriev IuK; Duganov VK; Bogdanov MB
    Voen Med Zh; 2000 Apr; 321(4):28-31. PubMed ID: 10860468
    [No Abstract]   [Full Text] [Related]  

  • 11. A cost-minimization analysis comparing azithromycin-based and levofloxacin-based protocols for the treatment of patients hospitalized with community-acquired pneumonia: results from the CAP-IN trial.
    Samsa GP; Matchar DB; Harnett J; Wilson J
    Chest; 2005 Nov; 128(5):3246-54. PubMed ID: 16304269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost of a ventilator-associated pneumonia in a shock trauma intensive care unit.
    Cocanour CS; Ostrosky-Zeichner L; Peninger M; Garbade D; Tidemann T; Domonoske BD; Li T; Allen SJ; Luther KM
    Surg Infect (Larchmt); 2005; 6(1):65-72. PubMed ID: 15865552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis of length of stay, total costs, and treatment success between intravenous moxifloxacin 400 mg and levofloxacin 750 mg among hospitalized patients with community-acquired pneumonia.
    Friedman H; Song X; Crespi S; Navaratnam P
    Value Health; 2009; 12(8):1135-43. PubMed ID: 19695010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial switch therapy.
    Bui K; Quintiliani R
    Conn Med; 1998 Nov; 62(11):665-8. PubMed ID: 9874890
    [No Abstract]   [Full Text] [Related]  

  • 15. [Evaluation of efficacy and duration of drug therapies for patients with nosocomial pneumonia].
    Comittee for the Japanese respiratory society guidlines in management of respiratory infections
    Nihon Kokyuki Gakkai Zasshi; 2008 Jun; Suppl():39-41. PubMed ID: 22675774
    [No Abstract]   [Full Text] [Related]  

  • 16. Prolongation of hospital stay and additional costs due to nosocomial bloodstream infection in an Algerian neonatal care unit.
    Atif ML; Sadaoui F; Bezzaoucha A; Kaddache CA; Boukari R; Djelato S; Boubechou N
    Infect Control Hosp Epidemiol; 2008 Nov; 29(11):1066-70. PubMed ID: 18826372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and economic consequences of ventilator-associated pneumonia.
    Amin A
    Clin Infect Dis; 2009 Aug; 49 Suppl 1():S36-43. PubMed ID: 19619020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Costs associated with nosocomial pneumonia in Universitary Hospital of Santander-Colombia, 2007-2009].
    Rodríguez-Burbano L; De La Hoz FP; Leal-Castro AL
    Rev Salud Publica (Bogota); 2013; 15(2):196-207. PubMed ID: 24892662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nosocomial pneumonia: third-group chinolone versus clindamycin/ceftriaxone in modulation of the acute phase reaction and outcome and cost efficacy.
    Reith HB; Rauchschwalbe SK; Mittelkötter U
    Int Surg; 2006; 91(5):272-5. PubMed ID: 17061673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of nosocomial pneumonia on a medical ward: a comparative study of outcomes and costs of invasive procedures.
    Herer B; Fuhrman C; Gazevic Z; Cabrit R; Chouaïd C
    Clin Microbiol Infect; 2009 Feb; 15(2):165-72. PubMed ID: 19154492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.